| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.06 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 0.07 |